1 Introduction Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for nearly one-third of global deaths each year ( The appeal of these agents stems from their capacity to modulate key pathophysiological contributors in atherosclerosis and heart failure, including oxidative stress, chronic vascular inflammation, endothelial dysfunction, dyslipidemia, and mitochondrial energy deficits ( However, the field is marked by heterogeneous and sometimes contradictory evidence
Ophiopogon polysaccharide liposome can enhance the non-specific and specific immune response in chickens
This is why doctors prefer products containing lutein zeaxanthin and omega 3 fatty acids , omega 3 lutein zeaxanthin tablets , and similar softgel formulations
This guide will explain the background of this situation, the legal framework that allows for compounding, and the critical differences between compounded and branded drugs
Statistical testing was performed using STATA version 17 (StataCorp, Texas, USA) and Prism version 10 (GraphPad Software Inc